SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001415889-24-015217
Filing Date
2024-06-03
Accepted
2024-06-03 18:58:26
Documents
1
Period of Report
2024-05-28

Document Format Files

Seq Description Document Type Size
1 form3-06032024_100622.html 3  
1 form3-06032024_100622.xml 3 1657
  Complete submission text file 0001415889-24-015217.txt   3306
Mailing Address 4851 TAMIAMI TRAIL N, SUITE 200 NAPLES FL 34103
Business Address 4851 TAMIAMI TRAIL N, SUITE 200 NAPLES FL 34103 239-302-1707
Enveric Biosciences, Inc. (Issuer) CIK: 0000890821 (see all company filings)

IRS No.: 954484725 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O ENVERIC BIOSCIENCES, INC. 4851 TAMIAMI TRAIL N SUITE 200 NAPLES FL 34103
Business Address
DeWitt Sheila (Reporting) CIK: 0002025032 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38286 | Film No.: 241015548